Supplementation with n-3 PUFAs inhibited lipogenesis, attenuated hepatic oxidative stress, decreased inflammation and increased insulin sensitivity, further to preserve hepatic architecture and prevent hepatic steatosis (39). Here, INS is linked to fatty liver disease.